|
|
|
|
Under art. 3 of the Rules Governing the OTC Registration Platform
“General Principles and Amendments to the Rules”:
3.1 GME shall exercise its functions in an open and non-discriminatory way.
(...)
3.5 GME may propose amendments to these Market Rules and notify them to all parties concerned by posting
them on its website or by other suitable means, allowing at least fifteen days for the submission of comments,
if any. Taking into account the comments received, GME shall then submit the proposed amendments (and the reasons therefor)
to the approval of the Minister of Economic Development, who shall decide after hearing the opinion of AEEG.
3.6 The procedure referred to in para. 3.4 above shall not apply to urgent amendments to the Rules having
the purpose of safeguarding the proper functioning of the market. Any such amendment proposed by GME shall have
effect as of the date of its publication on GME’s website and promptly submitted to the approval of the Minister
of Economic Development, who shall decide after hearing the opinion of AEEG. In case of non-approval, the amendment
shall cease to have effect as of the date of notification of the Minister’s decision to GME. GME shall timely
notify the outcome of the approval procedure to Market Participants by posting it on its website. |
|
|
|
|
|
|
|